Oral treatment | Parenteral treatment | |
---|---|---|
No risk of Pseudomonas spp. | Amoxicillin‐clavulanate Moxifloxacin Levofloxacin | |
Risk of Pseudomonas spp.a | Ciprofloxacinb | Ceftazidime, or carbapenem, or piperacillin‐tazobactam |
aUse the same criteria mentioned for chronic obstructive pulmonary disease exacerbation.
bLevofloxacin 750 mg/24 h or 500 mg twice daily is an alternative.